Considering the differences of tumorigenesis and clinical features between HBV-related HCC and non-HBV-related HCC, it is worthwhile to evaluate the prognosis predicting value of AFP in patients with HBV-related HCC, especially in Asian countries where HBV infection is endemic and a main causative factor of HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.